Skip to content

Public FDA record

Z-0138-2014: Stereotactic Circular Collimator - 3D Line stereotatic Hardware Accessories The device is part of the cl

Recall record Z-0138-2014 for Elekta, Inc.. View source facts, labeled dates, and the original FDA record.

FDA identifier
Z-0138-2014
Company in FDA record
Elekta, Inc.
FDA classification date
Nov 4, 2013
First observed by MedTech Watch
Nov 16, 2026
Latest observed content change
Nov 16, 2026
Recall classification
Class II

Reason stated in the source

Potential for clinical errors.

Source facts

Action
Elekta sent an Important Field Safety Notice dated 7/2013, to all affected customers. The letter identified the product the problem and the action needed to be taken by the customer. Customers were advised of the issue and recommendation to resolve either by upgrading their system or to discontinue a clinical use of the device. For further questions please call ( 770 ) 300-9725.
Initiated
2013-07-23
Root cause
No Marketing Application
Terminated
2014-11-18
Distribution
Nationwide distribution: USA including the states of AZ, CA, FL, GA, MO, NJ, NM, NC, OR, TN and WV.
Recall number
Z-0138-2014
Recall status
Terminated
CDRH record ID
120136
FDA classified
2013-11-04
Recall event number
65782

Source facts and excerpts are reproduced for research. Dates retain their source meanings. “First observed” describes collection, not FDA publication or product launch.

Recall classification is supplied only when the recall number matches an enforcement record. Recall class and device class are different fields. Several recall records may belong to one recall event.

Useful context

Device classifications

FDA dataset:

Last successful check: Nov 22, 2026

Source classifications may change.

510(k) clearances

FDA dataset:

Last successful check: Nov 22, 2026

FDA publishes this dataset monthly.

Recall records

FDA dataset:

Last successful check: Nov 22, 2026

FDA publishes this dataset weekly.

Keep this research moving.

Follow ten competitors and ten product codes. Get matching changes in your dashboard and a weekly brief, for $49/month.

Start a 14-day free trial ↗